期刊
ACTA PHARMACEUTICA SINICA B
卷 11, 期 5, 页码 1158-1174出版社
INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES
DOI: 10.1016/j.apsb.2021.03.013
关键词
Nanomedicines; Rheumatoid arthritis; Targeted drug delivery; Liposome; Micelle; Stimulus-responsive delivery systems; Immune tolerance; Inflammation resolution
资金
- National Natural Science Foundation of China [82003661]
The pathogenesis of rheumatoid arthritis (RA) has led to the development of effective therapeutic regimens, however there are still challenges such as inadequate response to current therapies and systemic toxicity. Nanomedicine research has been inspired to enhance drug delivery efficiency in RA treatment, offering new therapeutic strategies and approaches.
Increasing understanding of the pathogenesis of rheumatoid arthritis (RA) has remarkably promoted the development of effective therapeutic regimens of RA. Nevertheless, the inadequate response to current therapies in a proportion of patients, the systemic toxicity accompanied by long-term administration or distribution in non-targeted sites and the comprised efficacy caused by undesirable bioavailability, are still unsettled problems lying across the full remission of RA. So far, these existing limitations have inspired comprehensive academic researches on nanomedicines for RA treatment. A variety of versatile nanocarriers with controllable physicochemical properties, tailorable drug release pattern or active targeting ability were fabricated to enhance the drug delivery efficiency in RA treatment. This review aims to provide an up-to-date progress regarding to RA treatment using nanomedicines in the last 5 years and concisely discuss the potential application of several newly emerged therapeutic strategies such as inducing the antigen-specific tolerance, pro-resolving therapy or regulating the immunometabolism for RA treatments. (C) 2021 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据